Novartis Capital CORP

CIK 1443411 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Novartis Capital CORP.

Recent SEC filings

FiledFormAccession number
Mar 17, 2026424B50001104659-26-029551
Mar 17, 2026FWP0001104659-26-028714
Mar 16, 2026424B50001104659-26-028048
Nov 4, 2025424B50001104659-25-106338
Nov 4, 2025FWP0001104659-25-105779
Nov 3, 2025424B50001104659-25-105278
Sep 17, 2024424B50001104659-24-100712
Sep 16, 2024424B50001104659-24-100040
Sep 16, 2024F-3ASR0001104659-24-100011
Sep 16, 2024FWP0001104659-24-100282
Feb 14, 2020POSASR0001047469-20-000872
Feb 12, 2020424B50001047469-20-000837
Feb 12, 2020FWP0001104659-20-016892
Feb 12, 2020FWP0001104659-20-016891
Feb 11, 2020424B50001047469-20-000795
Jan 30, 2020F-3ASR0001047469-20-000609
Feb 17, 2017POSASR0001104659-17-010092
Feb 15, 2017424B50001047469-17-000686
Feb 15, 2017FWP0001104659-17-009402
Feb 14, 2017424B50001047469-17-000659
Nov 20, 2015POSASR0001104659-15-080366
Nov 18, 2015424B50001047469-15-008772
Nov 18, 2015FWP0001104659-15-079736
Nov 17, 2015424B50001047469-15-008723
Sep 18, 2015F-3ASR0001047469-15-007387